Skip to content Skip to sidebar Skip to footer

Understanding the Disproportionate CDI-Related Mortality and the Importance of Infection Prevention Initiatives

A recent national analysis that spanned a quarter of a century, presented at IDWeek 2025, reveals a sharp demographic skewness in deaths related to Clostridioides difficile infection (CDI) in the United States. This discussion unfolds within the parameters of a study conducted using Centers for Disease Control and Prevention (CDC) WONDER mortality data within the…

Read more

IDSA Showcases Pioneers in Infectious Diseases Research at IDWeek 2025

During the annual IDWeek 2025, the Infectious Diseases Society of America (IDSA) recognized twelve foremost specialists for their meaningful contributions to the field of infectious diseases. IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP expressed her deep delight in acknowledging these remarkable leaders, not just for their pivotal roles in combating infectious diseases, but also…

Read more

Understanding the Rising Threat of NDM-CRE Infections: Implications for Healthcare Providers

The United States is witnessing an alarming surge in human infections stemming from drug-resistant bacteria, warns the Centers for Disease Control and Prevention (CDC). The CDC lab tests have uncovered a dramatic increase in instances of a bacterium known as NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE). This bacterium is a subset of the broader category of bacteria…

Read more

Harnessing the Power of Monoclonal Antibodies: Invivyd’s Fight Against Infectious Diseases

In a recent episode of healthcare industry discussions, Marc Elia, Chairperson of the Board at Invivyd, provided fascinating insights into his personal journey battling COVID-19 and long-haul COVID. Being at the helm of Invivyd, a company renowned for its innovative monoclonal antibody platform, Elia shared a deep look into the company's groundbreaking work to address…

Read more

Illinois Gov. JB Pritzker Announces $1.5 Million Partnership with Chicago Hospitals to Strengthen State’s Readiness Against Infectious Diseases

The state of Illinois has fortified its healthcare infrastructure to ensure readiness against high-risk infectious diseases. Governor JB Pritzker announced a strategic alliance with two premier Chicago-based healthcare institutes - Rush University Medical Center and the Ann & Robert H. Lurie Children’s Hospital of Chicago. Known as Elite Special Pathogen Treatment Centers, these hospitals are…

Read more

Spotlight on a Leader in Infectious Disease Management: Dr. Suman Radhakrishna

Focusing on the impressive credentials and manifold responsibilities of Dr. Suman Radhakrishna, a preeminent infectious diseases expert based in Los Angeles, California. She is board-certified in both internal medicine and infectious diseases, and she holds the esteemed credential of being an HIV Specialist under the American Academy of HIV Medicine. As the head of the…

Read more

Dr. David Banach: Championing a Healthier World through Infectious Diseases Knowledge, Advocacy, and Compassion

Originating from Connecticut, Dr. David Banach has proven time and time again that one's roots can deeply impact one's career. Today, after a serpentine journey threaded with commitment, benevolence, and scientific grit, Dr. Banach stands tall as an esteemed Professor of Medicine at the University of Connecticut. However, his roles have extended beyond academic walls,…

Read more

The Effectiveness of Hand Hygiene: Insights from the NFID’s 2025 State of Handwashing Report

World Hand Hygiene Day was marked with a significant release from The National Foundation for Infectious Diseases (NFID), the 2025 State of Handwashing Report, based on a thorough survey of adult handwashing habits and comprehension in the United States. Sadly, the survey revealed troubling findings, with nearly half of US adults confessing they have failed…

Read more

Rising Trend in Infections from Carbapenem-Resistant Acinetobacter baumannii and a Snapshot of Current Health Concerns in the US

A recent analysis of hospital data in the United States indicates that Acinetobacter baumannii infections resistant to carbapenem, also known as CRAB, have been responsible for more than one-third of all A. baumannii infections from 2018 to 2022. The study, published in BMC Infectious Diseases, utilised data gleaned from 314 hospitals in the US and…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]